APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Carbohydrate Antigen 19-9

Compare research editions
View pricing & licenses

Selected research

Industry Research

Carbohydrate Antigen 19-9 Industry Research Report 2026

Report ID 173974940528 December 2025125 pages

Choose your research edition.

Industry ResearchCarbohydrate Antigen 19-9 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbohydrate Antigen 19-9 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Carbohydrate Antigen 19-9 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbohydrate Antigen 19-9 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbohydrate Antigen 19-9 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Carbohydrate Antigen 19-9 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Carbohydrate Antigen 19-9 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Carbohydrate Antigen 19-9 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Carbohydrate Antigen 19-9 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Carbohydrate Antigen 19-9 include BioMérieux, Danaher Corporation, DiaSorin, Fujirebio, KAINOS Laboratories, Ortho Clinical Diagnostics, Siemens, DIACHA Diagnostics and Dirui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Carbohydrate Antigen 19-9 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Carbohydrate Antigen 19-9 Market by Company

BioMérieux

Danaher Corporation

DiaSorin

Fujirebio

KAINOS Laboratories

Ortho Clinical Diagnostics

Siemens

DIACHA Diagnostics

Dirui

Roche

Chemclin IVD

Tellgen

Sichuan Maccura Biotechnology

Abbott

Carbohydrate Antigen 19-9 Segment by Type

ELISA

CLIA

Carbohydrate Antigen 19-9 Segment by Application

Pancreatic Cancer

Stomach Cancer

Colon Cancer

Others

Carbohydrate Antigen 19-9 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbohydrate Antigen 19-9 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbohydrate Antigen 19-9 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbohydrate Antigen 19-9.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Carbohydrate Antigen 19-9 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Carbohydrate Antigen 19-9 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Carbohydrate Antigen 19-9 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Carbohydrate Antigen 19-9 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Carbohydrate Antigen 19-9 Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Carbohydrate Antigen 19-9 Revenue of Manufacturers (2021-2026) Table 9. Global Carbohydrate Antigen 19-9 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Carbohydrate Antigen 19-9 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Carbohydrate Antigen 19-9 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Carbohydrate Antigen 19-9, Product Type & Application Table 14. Global Carbohydrate Antigen 19-9 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Carbohydrate Antigen 19-9 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. BioMérieux Company Information Table 19. BioMérieux Business Overview Table 20. BioMérieux Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. BioMérieux Carbohydrate Antigen 19-9 Product Portfolio Table 22. BioMérieux Recent Developments Table 23. Danaher Corporation Company Information Table 24. Danaher Corporation Business Overview Table 25. Danaher Corporation Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio Table 27. Danaher Corporation Recent Developments Table 28. DiaSorin Company Information Table 29. DiaSorin Business Overview Table 30. DiaSorin Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. DiaSorin Carbohydrate Antigen 19-9 Product Portfolio Table 32. DiaSorin Recent Developments Table 33. Fujirebio Company Information Table 34. Fujirebio Business Overview Table 35. Fujirebio Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Fujirebio Carbohydrate Antigen 19-9 Product Portfolio Table 37. Fujirebio Recent Developments Table 38. KAINOS Laboratories Company Information Table 39. KAINOS Laboratories Business Overview Table 40. KAINOS Laboratories Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio Table 42. KAINOS Laboratories Recent Developments Table 43. Ortho Clinical Diagnostics Company Information Table 44. Ortho Clinical Diagnostics Business Overview Table 45. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio Table 47. Ortho Clinical Diagnostics Recent Developments Table 48. Siemens Company Information Table 49. Siemens Business Overview Table 50. Siemens Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Siemens Carbohydrate Antigen 19-9 Product Portfolio Table 52. Siemens Recent Developments Table 53. DIACHA Diagnostics Company Information Table 54. DIACHA Diagnostics Business Overview Table 55. DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio Table 57. DIACHA Diagnostics Recent Developments Table 58. Dirui Company Information Table 59. Dirui Business Overview Table 60. Dirui Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Dirui Carbohydrate Antigen 19-9 Product Portfolio Table 62. Dirui Recent Developments Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Roche Carbohydrate Antigen 19-9 Product Portfolio Table 67. Roche Recent Developments Table 68. Chemclin IVD Company Information Table 69. Chemclin IVD Business Overview Table 70. Chemclin IVD Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio Table 72. Chemclin IVD Recent Developments Table 73. Tellgen Company Information Table 74. Tellgen Business Overview Table 75. Tellgen Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Tellgen Carbohydrate Antigen 19-9 Product Portfolio Table 77. Tellgen Recent Developments Table 78. Sichuan Maccura Biotechnology Company Information Table 79. Sichuan Maccura Biotechnology Business Overview Table 80. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio Table 82. Sichuan Maccura Biotechnology Recent Developments Table 83. Abbott Company Information Table 84. Abbott Business Overview Table 85. Abbott Carbohydrate Antigen 19-9 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Abbott Carbohydrate Antigen 19-9 Product Portfolio Table 87. Abbott Recent Developments Table 88. Global Carbohydrate Antigen 19-9 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Carbohydrate Antigen 19-9 Sales by Region (2021-2026) & (K Units) Table 90. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2021-2026) Table 91. Global Carbohydrate Antigen 19-9 Sales by Region (2027-2032) & (K Units) Table 92. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2027-2032) Table 93. Global Carbohydrate Antigen 19-9 Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2021-2026) Table 95. Global Carbohydrate Antigen 19-9 Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2027-2032) Table 97. North America Carbohydrate Antigen 19-9 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 99. North America Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 100. North America Carbohydrate Antigen 19-9 Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Carbohydrate Antigen 19-9 Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Carbohydrate Antigen 19-9 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 104. Europe Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 105. Europe Carbohydrate Antigen 19-9 Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Carbohydrate Antigen 19-9 Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Carbohydrate Antigen 19-9 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 114. South America Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 115. South America Carbohydrate Antigen 19-9 Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Carbohydrate Antigen 19-9 Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Carbohydrate Antigen 19-9 Sales by Type (2021-2026) & (K Units) Table 123. Global Carbohydrate Antigen 19-9 Sales by Type (2027-2032) & (K Units) Table 124. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2026) Table 125. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2027-2032) Table 126. Global Carbohydrate Antigen 19-9 Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Carbohydrate Antigen 19-9 Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2026) Table 129. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2027-2032) Table 130. Global Carbohydrate Antigen 19-9 Price by Type (2021-2026) & (US$/Unit) Table 131. Global Carbohydrate Antigen 19-9 Price by Type (2027-2032) & (US$/Unit) Table 132. Global Carbohydrate Antigen 19-9 Sales by Application (2021-2026) & (K Units) Table 133. Global Carbohydrate Antigen 19-9 Sales by Application (2027-2032) & (K Units) Table 134. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2026) Table 135. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2027-2032) Table 136. Global Carbohydrate Antigen 19-9 Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Carbohydrate Antigen 19-9 Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2026) Table 139. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2027-2032) Table 140. Global Carbohydrate Antigen 19-9 Price by Application (2021-2026) & (US$/Unit) Table 141. Global Carbohydrate Antigen 19-9 Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Carbohydrate Antigen 19-9 Distributors List Table 145. Carbohydrate Antigen 19-9 Customers List Table 146. Carbohydrate Antigen 19-9 Industry Trends Table 147. Carbohydrate Antigen 19-9 Industry Drivers Table 148. Carbohydrate Antigen 19-9 Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Carbohydrate Antigen 19-9 Product Image Figure 5. Global Carbohydrate Antigen 19-9 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Carbohydrate Antigen 19-9 Market Size (2021-2032) & (US$ Million) Figure 7. Global Carbohydrate Antigen 19-9 Sales (2021-2032) & (K Units) Figure 8. Global Carbohydrate Antigen 19-9 Average Price (US$/Unit) & (2021-2032) Figure 9. ELISA Product Image Figure 10. CLIA Product Image Figure 11. Pancreatic Cancer Product Image Figure 12. Stomach Cancer Product Image Figure 13. Colon Cancer Product Image Figure 14. Others Product Image Figure 15. Global Carbohydrate Antigen 19-9 Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Carbohydrate Antigen 19-9 Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Carbohydrate Antigen 19-9 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Carbohydrate Antigen 19-9 Sales by Region in 2025 Figure 21. Global Carbohydrate Antigen 19-9 Revenue by Region in 2025 Figure 22. North America Carbohydrate Antigen 19-9 Market Size by Country in 2025 Figure 23. North America Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 24. North America Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021-2032) Figure 25. United States Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Carbohydrate Antigen 19-9 Market Size by Country in 2025 Figure 28. Europe Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 29. Europe Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021-2032) Figure 30. Germany Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Carbohydrate Antigen 19-9 Market Size by Country in 2025 Figure 37. Asia Pacific Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021-2032) Figure 39. China Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Carbohydrate Antigen 19-9 Market Size by Country in 2025 Figure 48. South America Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 49. South America Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021-2032) Figure 50. Mexico Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Colombia Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Country in 2025 Figure 55. Middle East and Africa Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Carbohydrate Antigen 19-9 Revenue Market Share by Country (2021-2032) Figure 57. Turkey Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Carbohydrate Antigen 19-9 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2032) Figure 61. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2032) Figure 62. Global Carbohydrate Antigen 19-9 Price (US$/Unit) by Type (2021-2032) Figure 63. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2032) Figure 64. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2032) Figure 65. Global Carbohydrate Antigen 19-9 Price (US$/Unit) by Application (2021-2032) Figure 66. Carbohydrate Antigen 19-9 Value Chain Figure 67. Carbohydrate Antigen 19-9 Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Carbohydrate Antigen 19-9 Industry Opportunities and Challenges

Scope & coverage.

Types
  • ELISA
  • CLIA
Applications
  • Pancreatic Cancer
  • Stomach Cancer
  • Colon Cancer
  • Others
Companies covered
  • BioMérieux
  • Danaher Corporation
  • DiaSorin
  • Fujirebio
  • KAINOS Laboratories
  • Ortho Clinical Diagnostics
  • Siemens
  • DIACHA Diagnostics
  • Dirui
  • Roche
  • Chemclin IVD
  • Tellgen
  • Sichuan Maccura Biotechnology
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Carbohydrate Antigen 19-9 Market Size (2021-2032)
  4. 2.2.2 Global Carbohydrate Antigen 19-9 Sales (2021-2032)
  5. 2.2.3 Global Carbohydrate Antigen 19-9 Market Average Price (2021-2032)
  6. 2.3 Carbohydrate Antigen 19-9 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 ELISA
  9. 2.3.3 CLIA
  10. 2.4 Carbohydrate Antigen 19-9 by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Pancreatic Cancer
  13. 2.4.3 Stomach Cancer
  14. 2.4.4 Colon Cancer
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Carbohydrate Antigen 19-9 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Carbohydrate Antigen 19-9 Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Carbohydrate Antigen 19-9 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Carbohydrate Antigen 19-9 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Carbohydrate Antigen 19-9 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Carbohydrate Antigen 19-9, Product Type & Application
  8. 3.8 Global Manufacturers of Carbohydrate Antigen 19-9, Established Date
  9. 3.9 Global Carbohydrate Antigen 19-9 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 BioMérieux
  2. 4.1.1 BioMérieux Company Information
  3. 4.1.2 BioMérieux Business Overview
  4. 4.1.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 BioMérieux Carbohydrate Antigen 19-9 Product Portfolio
  6. 4.1.5 BioMérieux Recent Developments
  7. 4.2 Danaher Corporation
  8. 4.2.1 Danaher Corporation Company Information
  9. 4.2.2 Danaher Corporation Business Overview
  10. 4.2.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio
  12. 4.2.5 Danaher Corporation Recent Developments
  13. 4.3 DiaSorin
  14. 4.3.1 DiaSorin Company Information
  15. 4.3.2 DiaSorin Business Overview
  16. 4.3.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 DiaSorin Carbohydrate Antigen 19-9 Product Portfolio
  18. 4.3.5 DiaSorin Recent Developments
  19. 4.4 Fujirebio
  20. 4.4.1 Fujirebio Company Information
  21. 4.4.2 Fujirebio Business Overview
  22. 4.4.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Fujirebio Carbohydrate Antigen 19-9 Product Portfolio
  24. 4.4.5 Fujirebio Recent Developments
  25. 4.5 KAINOS Laboratories
  26. 4.5.1 KAINOS Laboratories Company Information
  27. 4.5.2 KAINOS Laboratories Business Overview
  28. 4.5.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio
  30. 4.5.5 KAINOS Laboratories Recent Developments
  31. 4.6 Ortho Clinical Diagnostics
  32. 4.6.1 Ortho Clinical Diagnostics Company Information
  33. 4.6.2 Ortho Clinical Diagnostics Business Overview
  34. 4.6.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
  36. 4.6.5 Ortho Clinical Diagnostics Recent Developments
  37. 4.7 Siemens
  38. 4.7.1 Siemens Company Information
  39. 4.7.2 Siemens Business Overview
  40. 4.7.3 Siemens Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Siemens Carbohydrate Antigen 19-9 Product Portfolio
  42. 4.7.5 Siemens Recent Developments
  43. 4.8 DIACHA Diagnostics
  44. 4.8.1 DIACHA Diagnostics Company Information
  45. 4.8.2 DIACHA Diagnostics Business Overview
  46. 4.8.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
  48. 4.8.5 DIACHA Diagnostics Recent Developments
  49. 4.9 Dirui
  50. 4.9.1 Dirui Company Information
  51. 4.9.2 Dirui Business Overview
  52. 4.9.3 Dirui Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Dirui Carbohydrate Antigen 19-9 Product Portfolio
  54. 4.9.5 Dirui Recent Developments
  55. 4.10 Roche
  56. 4.10.1 Roche Company Information
  57. 4.10.2 Roche Business Overview
  58. 4.10.3 Roche Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Roche Carbohydrate Antigen 19-9 Product Portfolio
  60. 4.10.5 Roche Recent Developments
  61. 4.11 Chemclin IVD
  62. 4.11.1 Chemclin IVD Company Information
  63. 4.11.2 Chemclin IVD Business Overview
  64. 4.11.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio
  66. 4.11.5 Chemclin IVD Recent Developments
  67. 4.12 Tellgen
  68. 4.12.1 Tellgen Company Information
  69. 4.12.2 Tellgen Business Overview
  70. 4.12.3 Tellgen Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Tellgen Carbohydrate Antigen 19-9 Product Portfolio
  72. 4.12.5 Tellgen Recent Developments
  73. 4.13 Sichuan Maccura Biotechnology
  74. 4.13.1 Sichuan Maccura Biotechnology Company Information
  75. 4.13.2 Sichuan Maccura Biotechnology Business Overview
  76. 4.13.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio
  78. 4.13.5 Sichuan Maccura Biotechnology Recent Developments
  79. 4.14 Abbott
  80. 4.14.1 Abbott Company Information
  81. 4.14.2 Abbott Business Overview
  82. 4.14.3 Abbott Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Abbott Carbohydrate Antigen 19-9 Product Portfolio
  84. 4.14.5 Abbott Recent Developments
5 Global Carbohydrate Antigen 19-9 Market Scenario by Region
  1. 5.1 Global Carbohydrate Antigen 19-9 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Carbohydrate Antigen 19-9 Sales by Region: 2021-2032
  3. 5.2.1 Global Carbohydrate Antigen 19-9 Sales by Region: 2021-2026
  4. 5.2.2 Global Carbohydrate Antigen 19-9 Sales by Region: 2027-2032
  5. 5.3 Global Carbohydrate Antigen 19-9 Revenue by Region: 2021-2032
  6. 5.3.1 Global Carbohydrate Antigen 19-9 Revenue by Region: 2021-2026
  7. 5.3.2 Global Carbohydrate Antigen 19-9 Revenue by Region: 2027-2032
  8. 5.4 North America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
  9. 5.4.1 North America Carbohydrate Antigen 19-9 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  11. 5.4.3 North America Carbohydrate Antigen 19-9 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Carbohydrate Antigen 19-9 Market Facts & Figures by Country
  15. 5.5.1 Europe Carbohydrate Antigen 19-9 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  17. 5.5.3 Europe Carbohydrate Antigen 19-9 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Carbohydrate Antigen 19-9 Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
  36. 5.7.1 South America Carbohydrate Antigen 19-9 Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  38. 5.7.3 South America Carbohydrate Antigen 19-9 Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Carbohydrate Antigen 19-9 Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021-2032)
  2. 6.1.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2021-2032)
  5. 6.2.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Carbohydrate Antigen 19-9 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021-2032)
  2. 7.1.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2021-2032)
  5. 7.2.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Carbohydrate Antigen 19-9 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Carbohydrate Antigen 19-9 Value Chain Analysis
  2. 8.1.1 Carbohydrate Antigen 19-9 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Carbohydrate Antigen 19-9 Production Mode & Process
  5. 8.2 Carbohydrate Antigen 19-9 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Carbohydrate Antigen 19-9 Distributors
  8. 8.2.3 Carbohydrate Antigen 19-9 Customers
9 Global Carbohydrate Antigen 19-9 Analyzing Market Dynamics
  1. 9.1 Carbohydrate Antigen 19-9 Industry Trends
  2. 9.2 Carbohydrate Antigen 19-9 Industry Drivers
  3. 9.3 Carbohydrate Antigen 19-9 Industry Opportunities and Challenges
  4. 9.4 Carbohydrate Antigen 19-9 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst